1. Optimal patient selection for stereotactic body radiotherapy – Authors' reply. Issue 12 (December 2019) Authors: Brand, Douglas H; Tree, Alison C; Hall, Emma; van As, Nicholas Journal: Lancet oncology Issue: Volume 20:Issue 12(2019) Page Start: e662 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial. Issue 11 (November 2019) Authors: Brand, Douglas H; Tree, Alison C; Ostler, Peter; van der Voet, Hans; Loblaw, Andrew; Chu, William; Ford, Daniel; Tolan, Shaun; Jain, Suneil; Martin, Alexander; Staffurth, John; Camilleri, Philip; Kancherla, Kiran; Frew, John; Chan, Andrew; Dayes, Ian S; Henderson, Daniel; Brown, Stephanie; Cruick... Journal: Lancet oncology Issue: Volume 20:Issue 11(2019) Page Start: 1531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial. Issue 11 (November 2019) Authors: Brand, Douglas H; Tree, Alison C; Ostler, Peter; van der Voet, Hans; Loblaw, Andrew; Chu, William; Ford, Daniel; Tolan, Shaun; Jain, Suneil; Martin, Alexander; Staffurth, John; Camilleri, Philip; Kancherla, Kiran; Frew, John; Chan, Andrew; Dayes, Ian S; Henderson, Daniel; Brown, Stephanie; Cruick... Journal: Lancet oncology Issue: Volume 20:Issue 11(2019) Page Start: 1531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The delineation of intraprostatic boost regions for radiotherapy using multimodality imaging. (November 2016) Authors: Pathmanathan, Angela U; Alexander, Emma J; Huddart, Robert A; Tree, Alison C Journal: Future oncology Issue: Volume 12:Number 21(2016) Page Start: 2495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Intermediate clinical endpoints in localised prostate cancer. Issue 3 (March 2021) Authors: Tree, Alison C; Dearnaley, David P; Hall, Emma Journal: Lancet oncology Issue: Volume 22:Issue 3(2021) Page Start: 294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial. Issue 10 (October 2022) Authors: Tree, Alison C; Ostler, Peter; van der Voet, Hans; Chu, William; Loblaw, Andrew; Ford, Daniel; Tolan, Shaun; Jain, Suneil; Martin, Alexander; Staffurth, John; Armstrong, John; Camilleri, Philip; Kancherla, Kiran; Frew, John; Chan, Andrew; Dayes, Ian S; Duffton, Aileen; Brand, Douglas H; Henderson... Journal: Lancet oncology Issue: Volume 23:Issue 10(2022) Page Start: 1308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Considering benefit and risk before routinely recommending SpaceOAR. Issue 1 (January 2021) Authors: Hall, William A; Tree, Alison C; Dearnaley, David; Parker, Christopher C; Prasad, Vinay; Roach, Mack; Lawton, Colleen A F Journal: Lancet oncology Issue: Volume 22:Issue 1(2021) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗